Thank you to everyone who came to Harrisburg yesterday. I am ceaselessly impressed by the work of our advocates who again rang out to tell @CMSGov we can’t wait any longer. Those living with Alz need #MoreTime , they need #AccessNow . #EndAlz#PaCapitol
https://t.co/UYDHfUlpyA
Progress like this simply DOES NOT HAPPEN without the work volunteer advocates have done across Pennsylvania to shed light on issues facing the Alzheimer's and dementia community. It's an honor to work alongside you and we'll never Thank you enough.
Breaking News: Pennsylvania @GovernorShapiro proposes a historic $1.9 million investment to support an Alzheimer's and dementia infrastructure. Read our full statement: https://t.co/bAqwCVzAMe
Thank you Governor Shapiro for supporting the 250,000 Pennsylvanian's living with Alzheimer's and their caregivers. Now it's time for our state legislators to match that energy and I believe they will because we've come too far to turn back now.
Breaking News: Pennsylvania @GovernorShapiro proposes a historic $1.9 million investment to support an Alzheimer's and dementia infrastructure. Read our full statement: https://t.co/bAqwCVzAMe
In addition to already signing on to show support for increased Alzheimer’s research funding, today @RepDwightEvans agreed to cosponsor The National Alz Project Reauthorization and The Alz Investment and Accountability Acts - Thank You for ensuring our work to #EndAlz continues
Thank You @RepDwightEvans for taking the time to hear from @alzdelval advocates. Members of the Alzheimer’s community spoke on research advancements, barriers to care and the every day work of caregivers.
The @alzdelval office in Philadelphia is ready. Today volunteer advocates will be joined by @RepDwightEvans to discuss Alzheimer’s and Dementia and the issues that face our community. #EndAlz
For the many we know, and for the millions we dont, the work of Alzheimer’s Association volunteer advocates for the last six months will be nothing short of life changing.
The era of treatment begins.
#AccessNow#MoreTime#EndAlz
Our advocates tirelessly shared their stories in all 50 states & it made a difference. Today, CMS announced their plan for Medicare coverage of FDA traditionally approved Alzheimer’s treatments, an important development for those living with this disease. https://t.co/BKEDcF6g7J
BREAKING NEWS: The FDA has granted lecanemab traditional approval for the treatment of early Alzheimer’s. Lecanemab is the first Alzheimer’s treatment granted this kind of approval that changes the underlying course of the disease. https://t.co/EIx77bTikR
A moment that shines a bright light on the great need for more investment in health equity, science, care delivery models, community infrastructure and health policy.
While we celebrate this moment, we know that there is much work to be done and we are looking forward. #ENDALZ
Back in Harrisburg with volunteer advocates speaking to lawmakers about the 280k Pennsylvanians living with Alzheimer’s and how we can support them and their caregivers. #EndAlz
.@CMSGov announced it will cover Alzheimer’s drugs upon traditional FDA approval with the caveat that patients must be enrolled in a registry. This remains a barrier and should not be required for coverage. Our statement: https://t.co/YbxfqUrpAk.
I’ve been off a couple of days. Congrats to the DC team and all the advocates who rallied across the country this week.
@CMSGov : in that time 14,000 more people aged out of the stage where new Alz treatments can help. #MoreTime for them was reasonable. #AccessNow is necessary.
“How is #MoreTime with family not reasonable? How is more time to be independent and plan for your future not necessary?” -Our president & CEO @joannepikedrph at today’s rally for #AccessNow at the @HHSGov building in Washington, D.C.
I want to thank everyone who came out in Downtown Philly to tell @CMSGov that more time for the 280,000 Pennsylvanians and ALL people living with Alzheimer’s IS ABSOLUTELY REASONABLE and ABSOLUTELY NECESSARY! #EndAlz#AccessNow#MoreTime